ID: MRFR/Pharma/4233-CR | 158 Pages | Author: Rahul Gotadki | October 2018
Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porterβs Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Hemophilia Market, by Type
6.1 Introduction
6.2 Hemophilia A
6.2.1 Market Estimates & Forecast, 2023 β 2030
6.3 Hemophilia B
6.3.1 Market Estimates & Forecast, 2023 β 2030
6.4 Hemophilia C
6.4.1 Market Estimates & Forecast, 2023 β 2030
6.5 Others
6.5.1 Market Estimates & Forecast, 2023 β 2030
Chapter 8. Global Hemophilia Market, by treatment
8.1 Introduction
8.2 Recombinant coagulation factor concentrates
8.2.1 Market Estimates & Forecast, 2023 β 2030
8.3 Plasma-derived coagulation factor concentrates
8.3.1 Market Estimates & Forecast, 2023 β 2030
8.4 Desmopressin
8.4.1 Market Estimates & Forecast, 2023 β 2030
8.5 Antifibrinolytic Agents
8.5.1 Market Estimates & Forecast, 2023 β 2030
Chapter 9. Global Hemophilia Market, by End Users
9.1 Introduction
9.2 Hospitals
9.2.1 Market Estimates & Forecast, 2023 β 2030
9.3 Clinics
9.3.1 Market Estimates & Forecast, 2023 β 2030
9.4 Diagnostic Centers
9.4.1 Market Estimates & Forecast, 2023 β 2030
9.5 Drug Stores
9.5.1 Market Estimates & Forecast, 2023 β 2030
9.6 Pharmacies
9.6.1 Market Estimates & Forecast, 2023 β 2030
9.7 Others
9.7.1 Market Estimates & Forecast, 2023 β 2030
Chapter 10. Global Hemophilia Market, by Region
10.1 Introduction
10.2 Americas
10.2.1 North America
10.2.1.1 U.S.
10.2.1.1 Canada
10.2.2 South America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 Germany
10.3.1.2 France
10.3.1.3 Italy
10.3.1.4 Spain
10.3.1.5 U.K
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 Republic of Korea
10.4.6 Rest of Asia Pacific
10.5 The Middle East & Africa
10.5.1 United Arab Emirates
10.5.2 Saudi Arabia
10.5.3 Oman
10.5.4 Kuwait
10.5.5 Qatar
10.5.6 Rest of the Middle East & Africa
Chapter 11 Company Landscape
11.1 Introduction
11.2 Market Share Analysis
11.3 Key Development & Strategies
11.3.1 Key Developments
Chapter 12 Company Profiles
12.1 Baxter International, Inc.
12.1.1 Company Overview
12.1.2 Types Overview
12.1.3 Financials
12.1.4 SWOT Analysis
12.2 Bayer AG
12.2.1 Company Overview
12.2.2 Types Overview
12.2.3 Financial Overview
12.2.4 Key Developments
12.2.5 SWOT Analysis
12.3 Biogen
12.3.1 Company Overview
12.3.2 Types Overview
12.3.3 Financial Overview
12.3.4 Key Development
12.3.5 SWOT Analysis
12.4 CSL Ltd.
12.4.1 Company Overview
12.4.2 Types/Business Segment Overview
12.4.3 Financial Overview
12.4.4 Key Development
12.4.5 SWOT Analysis
12.5 GENENTECH
12.5.1 Company Overview
12.5.2 Types Overview
12.5.3 Financial overview
12.5.4 Key Developments
12.6 GENENTECH Private Limited
12.6.1 Company Overview
12.6.2 Types Overview
12.6.3 Financial Overview
12.6.4 Key Developments
12.7 NOVO NORDISK
12.7.1 Overview
12.7.2 Types Overview
12.7.3 Financials
12.7.4 Key Developments
12.7.5 SWOT Analysis
12.8 Others
Chapter 13 MRFR Conclusion
13.1 Key Findings
13.1.1 From CEOβs View Point
13.1.2 Unmet Needs of the Market
13.2 Key Companies to Watch
13.3 Prediction of Hemophilia industry
Chapter 14 Appendix
LIST OF TABLES
Table 1 Hemophilia Industry Synopsis, 2023 β 2030
Table 2 Hemophilia Market Estimates and Forecast, 2023 β 2030, (USD Million)
Table 3 Hemophilia Market by Region, 2023 β 2030, (USD Million)
Table 4 Hemophilia Market by Type, 2023 β 2030, (USD Million)
Table 5 Hemophilia Market by Treatment, 2023 β 2030, (USD Million)
Table 6 Hemophilia Market by End User, 2023 β 2030, (USD Million)
Table 7 North America Hemophilia Market by Type, 2023 β 2030, (USD Million)
Table 8 North America Hemophilia Market by Treatment, 2023 β 2030, (USD Million)
Table 9 North America Hemophilia Market by End User, 2023 β 2030, (USD Million)
Table 10 US Hemophilia Market by Type, 2023 β 2030, (USD Million)
Table 11 US Hemophilia Market by Treatment, 2023 β 2030, (USD Million)
Table 12 US Hemophilia Market by End User, 2023 β 2030, (USD Million)
Table 13 Canada Hemophilia Market by Type, 2023 β 2030, (USD Million)
Table 14 Canada Hemophilia Market by Treatment, 2023 β 2030, (USD Million)
Table 15 Canada Hemophilia market by End User, 2023 β 2030, (USD Million)
Table 16 South America Hemophilia Market by Type, 2023 β 2030, (USD Million)
Table 17 South America Hemophilia Market by Treatment, 2023 β 2030, (USD Million)
Table 18 South America Hemophilia Market by End User, 2023 β 2030, (USD Million)
Table 19 Europe Hemophilia Market by Type, 2023 β 2030, (USD Million)
Table 20 Europe Hemophilia Market by Treatment, 2023 β 2030, (USD Million)
Table 21 Europe Hemophilia Market by End User, 2023 β 2030, (USD Million)
Table 22 Western Europe Hemophilia Market by Type, 2023 β 2030, (USD Million)
Table 23 Western Europe Hemophilia Market by Treatment, 2023 β 2030, (USD Million)
Table 24 Western Europe Hemophilia Market by End User, 2023 β 2030, (USD Million)
Table 25 Eastern Europe Hemophilia Market by Type, 2023 β 2030, (USD Million)
Table 26 Eastern Europe Hemophilia Market by Treatment, 2023 β 2030, (USD Million)
Table 27 Eastern Europe Hemophilia Market by End User, 2023 β 2030, (USD Million)
Table 28 Asia Pacific Hemophilia Market by Type, 2023 β 2030, (USD Million)
Table 29 Asia Pacific Hemophilia Market by Treatment, 2023 β 2030, (USD Million)
Table 30 Asia Pacific Hemophilia market by End User, 2023 β 2030, (USD Million)
Table 31 The Middle East & Africa Hemophilia Market by Type, 2023 β 2030, (USD Million)
Table 32 The Middle East & Africa Hemophilia Market by Treatment, 2023 β 2030, (USD Million)
Table 33 The Middle East & Africa Hemophilia market by End User, 2023 β 2030, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Hemophilia Market
Figure 3 Segmentation Market Dynamics for Hemophilia Market
Figure 4 Global Hemophilia market Share, by Type 2023
Figure 5 Global Hemophilia market Share, by Treatment 2023
Figure 6 Global Hemophilia market Share, by End User, 2023
Figure 7 Global Hemophilia market Share, by Region, 2023
Figure 8 North America Hemophilia market Share, by Country, 2023
Figure 9 Europe Hemophilia market Share, by Country, 2023
Figure 10 Asia Pacific Hemophilia market Share, by Country, 2023
Figure 11 Middle East & Africa Hemophilia market Share, by Country, 2023
Figure 12 Global Hemophilia market: Company Share Analysis, 2023 (%)
Figure 13 Baxter International, Inc.: Key Financials
Figure 14 Baxter International, Inc. Segmental Revenue
Figure 15 Baxter International, Inc. : Geographical Revenue
Figure 16 Bayer AG: Key Financials
Figure 17 Bayer AG: Segmental Revenue
Figure 18 Bayer AG: Geographical Revenue
Figure 19 Biogen: Key Financials
Figure 20 Biogen: Segmental Revenue
Figure 21 Biogen: Geographical Revenue
Figure 22 CSL Ltd.: Key Financials
Figure 23 CSL Ltd.: Segmental Revenue
Figure 24 CSL Ltd.: Geographical Revenue
Figure 25 GENENTECH: Key Financials
Figure 26 GENENTECH: Segmental Revenue
Figure 27 GENENTECH Geographical Revenue
Figure 28 GENENTECH Private Limited: Key Financials
Figure 29 GENENTECH Private Limited: Segmental Revenue
Figure 30 GENENTECH Private Limited: Geographical Revenue
Figure 31 NOVO NORDISK: Key Financials
Figure 32 NOVO NORDISK: Segmental Revenue
Figure 33 NOVO NORDISK: Geographical Revenue
Hemophilia Treatment Market Segmentation
Hemophilia Treatment Type Outlook (USD Billion, 2019-2030)
Hemophilia A
Hemophilia B
Hemophilia C
Hemophilia Treatment End-User Outlook (USD Billion, 2019-2030)
Hospital pharmacy
Retail pharmacy
Others
Hemophilia Treatment Regional Outlook (USD Billion, 2019-2030)
North America Outlook (USD Billion, 2019-2030)
North America Hemophilia Treatment by Type
Hemophilia A
Hemophilia B
Hemophilia C
North America Hemophilia Treatment by End-User
Hospital pharmacy
Retail pharmacy
Others
US Outlook (USD Billion, 2019-2030)
US Hemophilia Treatment by Type
Hemophilia A
Hemophilia B
Hemophilia C
US Hemophilia Treatment by End-User
Hospital pharmacy
Retail pharmacy
Others
CANADA Outlook (USD Billion, 2019-2030)
CANADA Hemophilia Treatment by Type
Hemophilia A
Hemophilia B
Hemophilia C
CANADA Hemophilia Treatment by End-User
Hospital pharmacy
Retail pharmacy
Others
Europe Outlook (USD Billion, 2019-2030)
Europe Hemophilia Treatment by Type
Hemophilia A
Hemophilia B
Hemophilia C
Europe Hemophilia Treatment by End-User
Hospital pharmacy
Retail pharmacy
Others
Germany Outlook (USD Billion, 2019-2030)
Germany Hemophilia Treatment by Type
Hemophilia A
Hemophilia B
Hemophilia C
Germany Hemophilia Treatment by End-User
Hospital pharmacy
Retail pharmacy
Others
France Outlook (USD Billion, 2019-2030)
France Hemophilia Treatment by Type
Hemophilia A
Hemophilia B
Hemophilia C
France Hemophilia Treatment by End-User
Hospital pharmacy
Retail pharmacy
Others
UK Outlook (USD Billion, 2019-2030)
UK Hemophilia Treatment by Type
Hemophilia A
Hemophilia B
Hemophilia C
UK Hemophilia Treatment by End-User
Hospital pharmacy
Retail pharmacy
Others
ITALY Outlook (USD Billion, 2019-2030)
ITALY Hemophilia Treatment by Type
Hemophilia A
Hemophilia B
Hemophilia C
ITALY Hemophilia Treatment by End-User
Hospital pharmacy
Retail pharmacy
Others
SPAIN Outlook (USD Billion, 2019-2030)
Spain Hemophilia Treatment by Type
Hemophilia A
Hemophilia B
Hemophilia C
Spain Hemophilia Treatment by End-User
Pharmaceutical Contract Manufacturing
Medical Device Contract Manufacturing
Rest Of Europe Outlook (USD Billion, 2019-2030)
Rest Of Europe Hemophilia Treatment by Type
Hemophilia A
Hemophilia B
Hemophilia C
REST OF EUROPE Hemophilia Treatment by End-User
Hospital pharmacy
Retail pharmacy
Others
Asia-Pacific Outlook (USD Billion, 2019-2030)
Asia-Pacific Hemophilia Treatment by Type
Hemophilia A
Hemophilia B
Hemophilia C
Asia-Pacific Hemophilia Treatment by End-User
Hospital pharmacy
Retail pharmacy
Others
China Outlook (USD Billion, 2019-2030)
China Hemophilia Treatment by Type
Hemophilia A
Hemophilia B
Hemophilia C
China Hemophilia Treatment by End-User
Hospital pharmacy
Retail pharmacy
Others
Japan Outlook (USD Billion, 2019-2030)
Japan Hemophilia Treatment by Type
Hemophilia A
Hemophilia B
Hemophilia C
Japan Hemophilia Treatment by End-User
Hospital pharmacy
Retail pharmacy
Others
India Outlook (USD Billion, 2019-2030)
India Hemophilia Treatment by Type
Hemophilia A
Hemophilia B
Hemophilia C
India Hemophilia Treatment by End-User
Pharmaceutical Contract Manufacturing
Medical Device Contract Manufacturing
Australia Outlook (USD Billion, 2019-2030)
Australia Hemophilia Treatment by Type
Hemophilia A
Hemophilia B
Hemophilia C
Australia Hemophilia Treatment by End-User
Hospital pharmacy
Retail pharmacy
Others
Rest of Asia-Pacific Outlook (USD Billion, 2019-2030)
Rest of Asia-Pacific Hemophilia Treatment by Type
Hemophilia A
Hemophilia B
Hemophilia C
Rest of Asia-Pacific Hemophilia Treatment by End-User
Hospital pharmacy
Retail pharmacy
Others
Rest of the World Outlook (USD Billion, 2019-2030)
Rest of the World Hemophilia Treatment by Type
Hemophilia A
Hemophilia B
Hemophilia C
Rest of the World Hemophilia Treatment by End-User
Hospital pharmacy
Retail pharmacy
Others
Middle East Outlook (USD Billion, 2019-2030)
Middle East Hemophilia Treatment by Type
Hemophilia A
Hemophilia B
Hemophilia C
Middle East Hemophilia Treatment by End-User
Hospital pharmacy
Retail pharmacy
Others
Africa Outlook (USD Billion, 2019-2030)
Africa Hemophilia Treatment by Type
Hemophilia A
Hemophilia B
Hemophilia C
Africa Hemophilia Treatment by End-User
Hospital pharmacy
Retail pharmacy
Others
Latin America Outlook (USD Billion, 2019-2030)
Latin America Hemophilia Treatment by Type
Hemophilia A
Hemophilia B
Hemophilia C
Latin America Hemophilia Treatment by End-User
Hospital pharmacy
Retail pharmacy
Others